Company information:
Allergan Development Ventures I Uk (No: 09315130)
Address: C/O MILSTED LANGDON LLP, 46-48 EAST SMITHFIELD, LONDON, E1W 1AW
Status: Liquidation
Incorporated: 17-Nov-2014
Next Confirmation Statement Due: 14-Jun-2019
Industry Class: 72110 - Research and experimental development on biotechnology
Current Director: PAUL JOHNSON ( DOB: Dec-1972 From: Aug-2018 )
Current Secretary: PATRICIA MARIA HARAN ( From: Feb-2018 )
Current Secretary: JUDITH TOMKINS ( From: Feb-2018 )
Resigned Director: CAROLE CHAPPELL ( DOB: Apr-1960 From: Nov-2014 To: Nov-2015 )
Resigned Director: MARTIN PHILIP JACOB ( From: Nov-2014 To: Nov-2014 )
Resigned Director: DAVID PAUL KENNY ( From: Nov-2014 To: Nov-2014 )
Resigned Director: SAMANTHA MARJORIE KERR ( DOB: Jul-1972 From: Nov-2014 To: Aug-2018 )
Resigned Secretary: MARTIN PHILIP JACOB ( From: Nov-2014 To: Nov-2014 )
Resigned Secretary: TOM NELLIGAN ( From: Nov-2014 To: Oct-2017 )
Persons of Significant Control:
Allergan Holdco Uk Limited, 1st Floor Marlow International, Parkway, Marlow, Buckinghamshire, SL7 1YL, England: Ownership of shares – 75% or more, Ownership of voting rights - 75% or more, Right to appoint and remove directors (Notified: 2018-05-30)